NNGH
NNGH is a stromelysin-1 (MMP-3) inhibitor. MMP-3 is both a direct transcriptional target and a necessary contributor of the Wnt/β-catenin signaling pathway. Matrix metalloproteinases (MMPs) play a well-defined role in later stages of tumor progression[1].
Product Specifications
CAS Number
161314-17-6
UNSPSC
12352005
Target
MMP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nngh.html
Purity
99.6
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ONC(CN(CC(C)C)S(C1=CC=C(C=C1)OC)(=O)=O)=O
Molecular Formula
C13H20N2O5S
Molecular Weight
316.37
References & Citations
[1]Laurence Blavier, et al. Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT) . Cancer Biol Ther. 2010 Jul 15;10 (2) :198-208.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1646927-01 20 µg
Recombinant Oncorhynchus keta L-rhamnose-binding lectin CSL3
Sign In for Pricing
View Details orb1646927-02 100 µg
Recombinant Oncorhynchus keta L-rhamnose-binding lectin CSL3
Sign In for Pricing
View Details orb1646927-03 1 mg
Recombinant Oncorhynchus keta L-rhamnose-binding lectin CSL3
Sign In for Pricing
View Details K3215104 1.0 µg DNA
1700011I03Rik sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details